Evaluating Oral Probiotics and Prebiotics
- Publisher's listprice EUR 140.99
-
55 070 Ft (52 448 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 20% (cc. 11 014 Ft off)
- Discounted price 44 056 Ft (41 958 Ft + 5% VAT)
- Discount is valid until: 30 June 2026
Subcribe now and take benefit of a favourable price.
Subscribe
55 070 Ft
Availability
Not yet published.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 1 September 2026
- ISBN 9780443298356
- Binding Paperback
- No. of pages320 pages
- Size 229x152 mm
- Weight 450 g
- Language English 0
Categories
Long description:
Evaluating Oral Probiotics and Prebiotics reviews emerging applications of new probiotic strains, postbiotics, and production of key synbiotic generations. The book discusses successes and failures of viable probiotic ingestion, new trends and strains including genetically engineered probiotics, assessment of nonviable probiotics (postbiotics) and microflora benefits of prebiotic and synbiotic ingestion over probiotics.
MoreTable of Contents:
Section 1. Traditional trends on oral probiotic
1. The concept of microbiome in human body
2. Initial and traditional definition, concept and strains of probiotic
3. Viable probiotic ingestion strategy in drugs: a critical approach on health effectiveness, technological challenges, and consumer view
4. Viable probiotic ingestion strategy in supplements: a critical approach on health effectiveness, technological challenges, and consumer view
5. Viable probiotic ingestion strategy in foods: a critical approach on health effectiveness, technological challenges, and consumer view
6. The economy of probiotic in drugs, supplements and foods, and the future trend
7. The regulations associated to the viable probiotics in industrial products (drugs, supplements and food products)
8. The failure aspects of viable probiotic ingestion via drugs, supplements and foods Section
Section 2. New trends on oral probiotic
9. New definitions, concept and strains of probiotic
10. Non-viable probiotic ingestion strategy: research facts and usage in drug, supplements and food industries.
11. A critical approach on probiotic effectiveness and technological challenges when incorporated as viable or nonviable (postbiotic)
12. The quality factors for assessment of nonviable probiotic (postbiotic)
13. The failure aspects of non-viable probiotic ingestion via drugs, supplements and foods
14. Genetically-engineered probiotics (added based on reviewer feedback)
15. The new generations of probiotic and its future trend in industrial products (drug, supplement and food)
Section 3. Trends on prebiotic and synbiotic ingestion instead of probiotic
16. Incorporation of prebiotic in industrial drugs, supplements and food products: health effectiveness, technological challenges, consumer view, and the future trend
17. The economy of prebiotic in drugs, supplements and foods, and the future trend
18. A critical approach on effectiveness of prebiotic against probiotic in enhancing and promoting the native probiotic microflora in human body
19. The new generations of prebiotic and its future trend in industrial products (drug, supplement and food)
20. The regulations associated to the industrial prebiotic products (drugs, supplements and food products)
21. The health effectiveness, technological challenges and market of symbiotic instead of self-probiotic or self-prebiotic
22. Probiotic, prebiotic and synbiotic product development: principles, challenges, market and trends
